473 S.W.3d 861
Tex. App.2015Background
- Plaintiff Sushma Vora participated in a pre‑market, open‑label linaclotide drug study conducted by Diagnostic Research Group (DRG); Dr. John Holcomb was the study’s Principal Investigator.
- While in the study Vora experienced three severe adverse events (SAEs), each resulting in hospitalization; she was removed from the study after the third and subsequently suffered seizures and strokes.
- Vora sued DRG and Dr. Holcomb for negligence and gross negligence, alleging they departed from accepted medical standards by conducting the study and allowing her to continue on linaclotide despite serious side effects.
- Vora served an expert report from Dr. Amy Mulroy (a board‑certified psychiatrist/neurologist with extensive experience as a Principal Investigator in pre‑market drug studies); DRG and Holcomb objected to the report and moved to dismiss under the Texas Medical Liability Act (TMLA) for failure to timely and adequately serve a qualifying expert report.
- The trial court overruled objections, found claims against Holcomb were TMLA health care liability claims but concluded claims against DRG were not, and denied the motion to dismiss; DRG and Holcomb appealed interlocutorily.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether Vora's claims against DRG are "health care liability claims" under the TMLA | Vora contends her negligence claims are not TMLA claims; but she served an expert report to preserve rights | DRG argues it is a health care provider (affiliate of physician) so claims are TMLA and subject to expert‑report dismissal rules | Court: Affirmed trial court — on the sparse record DRG did not prove it is a licensed health‑care provider or an affiliate of Holcomb, so claims against DRG are not TMLA claims |
| Whether Dr. Mulroy is qualified to opine on causation for claims against Dr. Holcomb | Vora: Mulroy’s PI experience in many pre‑market studies qualifies her to opine about investigator duties and causation | Holcomb: Mulroy lacks specific experience with linaclotide, GI conditions, or causation for these injuries | Court: Affirmed trial court — Mulroy’s PI experience gave her sufficient familiarity with the issues to be a qualified causation expert |
| Whether Mulroy’s expert report adequately explains causation under Tex. Civ. Prac. & Rem. Code § 74.351 | Vora: Report explains PI standard of care, breach and links breach to continued drug use causing SAE | Holcomb: Report is conclusory on causation, lacks factual bases (e.g., review of medical records) and fails to explain how omissions caused the third hospitalization | Court: Reversed trial court in part — report is deficient on causation (insufficient factual linkage); trial court abused discretion by denying dismissal without giving plaintiff an opportunity to cure |
| Appropriate remedy when report is deficient | Vora: If deficient, she should be allowed to cure under § 74.351(c) | Defendants: Dismissal with prejudice | Court: Remanded — deficiency is curable; trial court should consider allowing the statutorily permitted 30‑day extension to cure rather than immediate dismissal |
Key Cases Cited
- San Antonio Extended Med. Care, Inc. v. Vasquez, 327 S.W.3d 193 (Tex. App.—San Antonio 2010) (abuse‑of‑discretion review of § 74.351 rulings)
- Loaisiga v. Cerda, 379 S.W.3d 248 (Tex. 2012) (health‑care‑liability‑claim analysis and considering the entire record)
- Bioderm Skin Care, LLC v. Sok, 426 S.W.3d 753 (Tex. 2014) (definition and proof requirements for "health care provider" and affiliates under TMLA)
- Palacios v. American Transitional Care Centers of Texas, 46 S.W.3d 873 (Tex. 2001) (four‑corners rule for expert reports under § 74.351)
- Jelinek v. Casas, 328 S.W.3d 526 (Tex. 2010) (conclusory expert opinions on causation are insufficient for § 74.351)
- Leland v. Brandal, 257 S.W.3d 204 (Tex. 2008) (one 30‑day extension to cure deficient expert reports under § 74.351)